PetMed Express, Inc. (NASDAQ:PETS – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.25 and traded as high as $5.00. PetMed Express shares last traded at $4.99, with a volume of 213,574 shares.
Wall Street Analysts Forecast Growth
Separately, StockNews.com upgraded PetMed Express from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th.
View Our Latest Report on PetMed Express
PetMed Express Stock Performance
PetMed Express (NASDAQ:PETS – Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.17. The business had revenue of $59.57 million during the quarter, compared to analysts’ expectations of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. Analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.
Insider Activity
In related news, Director Leslie C.G. Campbell purchased 15,000 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were acquired at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the acquisition, the director now owns 70,000 shares of the company’s stock, valued at $376,600. The trade was a 27.27 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.10% of the company’s stock.
Hedge Funds Weigh In On PetMed Express
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC purchased a new position in PetMed Express during the 2nd quarter worth $797,000. Bleakley Financial Group LLC purchased a new position in shares of PetMed Express in the 3rd quarter valued at approximately $279,000. Squarepoint Ops LLC acquired a new stake in PetMed Express in the 2nd quarter worth approximately $273,000. Sei Investments Co. grew its position in PetMed Express by 8.3% during the 2nd quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock worth $179,000 after purchasing an additional 3,400 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in PetMed Express during the 2nd quarter valued at approximately $135,000. Hedge funds and other institutional investors own 73.33% of the company’s stock.
PetMed Express Company Profile
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Further Reading
- Five stocks we like better than PetMed Express
- Why Are Stock Sectors Important to Successful Investing?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 3 Small Caps With Big Return Potential
- 3 Steel Stocks Soaring After Tariff Announcements
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.